secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001380106-25-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro prelim Q4 rev record $8.2M, +30% YoY; Lonza collaboration
---------------------------------------------------------------------

- Q4 total revenue preliminary ~$8.2M (record), +30% YoY; recurring rev ~$4.2M, +27% YoY.
- FY 2024 total rev ~$28.1M, +25% YoY; recurring rev ~$15.5M, +14% YoY.
- Placed 6 new Growth Direct systems in Q4; 21 systems placed in FY 2024; cumulative >160 placed globally.
- Collaborated with Lonza to integrate Growth Direct with MODA-EM; Lonza deploying across global cell and gene therapy network.
- Preliminary results unaudited; final results and 2025 outlook expected later in Q1 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000009/0001380106-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000009/rpid-20250114.htm
  HTML page:      https://secwatch.observer/filing/0001380106-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer